Business Standard

Wednesday, December 25, 2024 | 11:20 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Adar Poonawalla, CEO of Serum Institute of India Ltd
Premium

Adar Poonawalla, CEO of Serum Institute of India Ltd. (Photo: Bloomberg)

Sohini Das Mumbai
The world’s largest vaccine maker Serum Institute of India (SII) which is making the AstraZeneca and Novavax vaccines for Covid-19 in India said that it may start supplies to the global Covid vaccine alliance Covax by the end of this year. In a statement the firm also noted that it continues to prioritise India and has never exported Covid vaccines at the ‘cost of the people in India’.

In a message posted on micro-blogging site Twitter, SII said that it has delivered more than 200 million doses, even though it received EUA two months after the US pharma companies. “If

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in